プロトンポンプ阻害剤の世界市場レポート 2025年

プロトンポンプ阻害剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.4％で43億7,000万米ドルに成長します。予測期間の成長は、新興市場での採用、ヘリコバクター・ピロリ感染の増加、患者教育イニシアティブ、戦略的マーケティング、プロモーションによるものと考えられます。予測期間の主な動向としては、デジタルヘルスソリューションとの統合、世界市場の拡大、胃腸健康教育への注力、規制の更新、安全対策、環境への影響への配慮などが挙げられます。

プロトンポンプ阻害剤市場の成長は、胃腸障害の有病率の増加によって牽引されると予測されます。胃腸障害には、吐き気、嘔吐、食中毒、下痢など、胃腸（GI）管に影響を及ぼすさまざまな症状が含まれます。プロトンポンプ阻害剤（PPI）は、胃酸の分泌を抑えることにより、胸やけや酸関連疾患の管理に重要な役割を果たしています。胃腸疾患の罹患率が上昇していることは、Cancer Australiaのような組織の統計が証明しており、胃がんの罹患数は2022年に2,572人に達すると予測されています。さらに、米国消化器病学会（American Gastroenterological Association）の洞察によると、過去1年間にアメリカ人の40%以上が重度の胃腸症状によって日常生活を制限していることが明らかになっています。このような個人の生活への大きな影響は、プロトンポンプ阻害剤のような効果的な治療の必要性をさらに強調しています。

ヘリコバクター・ピロリ感染の増加は、プロトンポンプ阻害薬市場の成長に寄与すると予想されています。ヘリコバクター・ピロリ菌は、小腸上部や胃の粘膜に影響を及ぼす細菌感染症です。PPIは一般的にピロリ菌感染症の治療計画の一部として処方され、抗生物質と併用されることが多いです。Best Practice Advocacy Centre New Zealandが強調しているように、ピロリ菌感染症の世界の流行は、世界の50％以上の人々が感染しており、アフリカ、アジア、ラテンアメリカではより高い感染率であることから、この細菌感染症に対処するプロトンポンプ阻害剤のような効果的な治療法が広く必要とされていることが強調されています。胃腸障害とピロリ菌感染という二重の影響により、PPIが一般的な健康問題に対処し、市場成長を促進する上で重要な役割を担っていることが強調されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界プロトンポンプ阻害剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のプロトンポンプ阻害剤市場：成長率分析
• 世界のプロトンポンプ阻害剤市場の実績：規模と成長, 2019-2024
• 世界のプロトンポンプ阻害剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界プロトンポンプ阻害剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のプロトンポンプ阻害剤市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• パントプラゾール
• オメプラゾール
• ランソプラゾール
• エソメプラゾール
• ラベプラゾール
• デキランソプラゾール
• その他のタイプ
• 世界のプロトンポンプ阻害剤市場疾患別流通、実績と予測, 2019-2024, 2024-2029F, 2034F
• 潰瘍
• 胃食道逆流症
• その他の疾患の兆候
• 世界のプロトンポンプ阻害剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他の用途
• 世界のプロトンポンプ阻害剤市場パントプラゾールのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤処方
• 注射剤
• 世界のプロトンポンプ阻害剤市場オメプラゾールのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 市販薬（OTC）オメプラゾール
• 処方オメプラゾール
• 世界のプロトンポンプ阻害剤市場ランソプラゾールのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 即効性ランソプラゾール
• 徐放性ランソプラゾール
• 世界のプロトンポンプ阻害剤市場エソメプラゾールのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口エソメプラゾール
• 静脈内エソメプラゾール
• 世界のプロトンポンプ阻害剤市場ラベプラゾールのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラベプラゾール錠
• 徐放性ラベプラゾール
• 世界のプロトンポンプ阻害剤市場、デキランソプラゾールのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準デキランソプラゾール
• 徐放性デキランソプラゾール
• 世界のプロトンポンプ阻害剤市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 配合処方
• あまり知られていないPPI

第7章 地域別・国別分析

• 世界のプロトンポンプ阻害剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のプロトンポンプ阻害剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• プロトンポンプ阻害剤市場：競合情勢
• プロトンポンプ阻害剤市場：企業プロファイル
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Cadila Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
  • Eisai Pharmaceuticals India Pvt. Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Wyeth LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Eli Lilly and Company
• Bayer AG
• Takeda Pharmaceutical Company
• Santarus Inc.
• Janssen Pharmaceuticals
• GlaxoSmithKline plc
• Changzhou Siyao Pharmaceuticals
• Yangzhou Pharmaceutical
• Sanofi S.A.
• Johnson & Johnson
• Novartis International AG
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• プロトンポンプ阻害剤市場2029：新たな機会を提供する国
• プロトンポンプ阻害剤市場2029：新たな機会を提供するセグメント
• プロトンポンプ阻害剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Proton pump inhibitors (PPIs) constitute a category of medications designed to diminish the production of stomach acid. They find application in addressing conditions arising from either an excessive production of stomach acid or conditions aggravated by such acidity, including acid reflux and stomach ulcers.

The primary types of proton pump inhibitors encompass pantoprazole, omeprazole, lansoprazole, esomeprazole, rabeprazole, dexlansoprazole, and other derivatives. Pantoprazole, belonging to the proton pump inhibitor class, operates by reducing the volume of acid generated by the stomach. These medications play a crucial role in the treatment of ulcers, gastroesophageal reflux disease (GERD), and other related conditions. The usage of proton pump inhibitors is widespread in various healthcare settings, including hospitals, clinics, and other treatment centers, where they contribute significantly to managing acid-related disorders.

The proton pump inhibitors market research report is one of a series of new reports from The Business Research Company that provides proton pump inhibitors market statistics, including proton pump inhibitors industry global market size, regional shares, competitors with a proton pump inhibitors market share, detailed proton pump inhibitors market segments, market trends, and opportunities, and any further data you may need to thrive in the proton pump inhibitors industry. This proton pump inhibitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The proton pump inhibitors market size has grown steadily in recent years. It will grow from$3.4 billion in 2024 to $3.55 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to the prevalence of gastroesophageal reflux disease (GERD), peptic ulcer disease incidence, rising aging population, changing lifestyles, and dietary habits, and increasing awareness and diagnosis

The proton pump inhibitors market size is expected to see strong growth in the next few years. It will grow to $4.37 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to emerging markets adoption, growth in helicobacter pylori infections, patient education initiatives, strategic marketing, and promotions. Major trends in the forecast period include integration with digital health solutions, global market expansion, focus on gastrointestinal health education, regulatory updates, and safety measures, and environmental impact considerations.

The growth of the proton pump inhibitors market is anticipated to be driven by the increasing prevalence of gastrointestinal disorders. Gastrointestinal disorders encompass a range of conditions affecting the gastrointestinal (GI) tract, including nausea, vomiting, food poisoning, and diarrhea. Proton pump inhibitors (PPIs) play a crucial role in managing heartburn and acid-related disorders by reducing the production of stomach acid. The rising incidence of gastrointestinal disorders, as evidenced by statistics from organizations such as Cancer Australia, where stomach cancer cases are projected to reach 2,572 in 2022, underscores the demand for PPIs in addressing these health challenges. Additionally, insights from the American Gastroenterological Association reveal that severe gastrointestinal symptoms have led over 40% of Americans to curtail daily activities in the past year. This substantial impact on individuals' lives further emphasizes the need for effective treatments such as proton pump inhibitors.

The increased occurrence of Helicobacter pylori infections is expected to contribute to the growth of the proton pump inhibitor market. Helicobacter pylori is a bacterial infection affecting the upper part of the small intestine and the stomach lining. PPIs are commonly prescribed as part of treatment plans for H. pylori infections, often in combination with antibiotics. The global prevalence of H. pylori infections, highlighted by the Best Practice Advocacy Centre New Zealand, with over 50% of people worldwide infected and higher rates in Africa, Asia, and Latin America, emphasizes the widespread need for effective therapies such as proton pump inhibitors to address this bacterial infection. This dual influence of gastrointestinal disorders and H. pylori infections underscores the significant role PPIs play in addressing prevalent health issues and driving market growth.

Major companies in the proton pump inhibitors market are focusing on technological advancements, such as the introduction of Rabeprazole + Levosulpiride SR Capsules, to enhance the treatment of acid-related disorders. These capsules are a novel medication aimed at addressing gastrointestinal issues like gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS). For example, in June 2024, Akums Drugs & Pharmaceuticals, an India-based pharmaceutical company, launched the Rabeprazole + Levosulpiride SR Capsules. This combination medication is designed to treat acid-related gastrointestinal disorders, including GERD, functional dyspepsia, and other conditions associated with excess stomach acid and impaired digestive motility.

Companies in the proton pump inhibitor market are also directing their efforts towards obtaining approvals for innovative products. One such instance is the U.S. Food and Drug Administration (FDA) approval of KONVOMEP, an oral suspension containing omeprazole and sodium bicarbonate. This product aims to treat active benign gastric ulcers and reduce the risk of upper gastrointestinal bleeding in critically ill patients. KONVOMEP, being a liquid mixture of sodium bicarbonate and the proton pump inhibitor omeprazole, is particularly beneficial for individuals who have difficulty swallowing tablets or capsules. Azurity Pharmaceuticals, Inc., a US-based pharmaceutical company, secured FDA approval for Konvomep in September 2022, addressing the need for liquid medication options, especially for those with difficulty swallowing solid oral doses.

In July 2022, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, acquired the Abbreviated New Drug Application (ANDA) for famotidine tablets from Wockhardt, marking a strategic move in expanding its presence in the American over-the-counter (OTC) market. The acquired ANDA includes famotidine tablets, cetirizine hydrochloride tablets, lansoprazole delayed-release capsules, and olopatadine hydrochloride ophthalmic solution. This acquisition reflects Glenmark's commitment to ensuring patient access to high-quality and affordable medications.

Major companies operating in the proton pump inhibitors market include AstraZeneca plc, Pfizer Inc., Cadila Pharmaceuticals Limited, Eisai Pharmaceuticals India Pvt. Ltd, Wyeth LLC, Eli Lilly and Company, Bayer AG, Takeda Pharmaceutical Company, Santarus Inc., Janssen Pharmaceuticals, GlaxoSmithKline plc, Changzhou Siyao Pharmaceuticals, Yangzhou Pharmaceutical, Sanofi S.A., Johnson & Johnson, Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Cipla Limited, Hetero Drugs Limited, Intas Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Micro Labs Ltd., Natco Pharma Limited, Panacea Biotec Ltd., Strides Pharma Science Limited, Wockhardt Ltd.

North America was the largest region in the proton pump inhibitors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global proton pump inhibitors market size during the forecast period. The regions covered in the proton pump inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the proton pump inhibitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The proton pump inhibitors market consists of sales of pantoprazole, and lansoprazole DR. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Proton Pump Inhibitors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on proton pump inhibitors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for proton pump inhibitors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The proton pump inhibitors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Pantoprazole; Omeprazole; Lansoprazole; Esomeprazole; Rabeprazole; Dexlansoprazole; Other Types
• 2) By Disease Allocation: Ulcers; Gastroesophageal Reflux Disease; Other Disease Indications
• 3) By Application: Hospitals; Clinic; Other Applications
• Subsegments:
• 1) By Pantoprazole: Tablet Formulations; Injectable Formulations
• 2) By Omeprazole: Over-The-Counter (OTC) Omeprazole; Prescription Omeprazole
• 3) By Lansoprazole: Fast-Acting Lansoprazole; Delayed-Release Lansoprazole
• 4) By Esomeprazole: Oral Esomeprazole; Intravenous Esomeprazole
• 5) By Rabeprazole: Rabeprazole Tablets; Extended-Release Rabeprazole
• 6) By Dexlansoprazole: Standard Dexlansoprazole; Modified-Release Dexlansoprazole
• 7) By Other Types: Combination Formulations; Lesser-Known PPIs
• Companies Mentioned: AstraZeneca plc; Pfizer Inc.; Cadila Pharmaceuticals Limited; Eisai Pharmaceuticals India Pvt. Ltd; Wyeth LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Proton Pump Inhibitors Market Characteristics

3. Proton Pump Inhibitors Market Trends And Strategies

4. Proton Pump Inhibitors Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Proton Pump Inhibitors Growth Analysis And Strategic Analysis Framework

• 5.1. Global Proton Pump Inhibitors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Proton Pump Inhibitors Market Growth Rate Analysis
• 5.4. Global Proton Pump Inhibitors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Proton Pump Inhibitors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Proton Pump Inhibitors Total Addressable Market (TAM)

6. Proton Pump Inhibitors Market Segmentation

• 6.1. Global Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pantoprazole
• Omeprazole
• Lansoprazole
• Esomeprazole
• Rabeprazole
• Dexlansoprazole
• Other Types
• 6.2. Global Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ulcers
• Gastroesophageal Reflux Disease
• Other Disease Indications
• 6.3. Global Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinic
• Other Applications
• 6.4. Global Proton Pump Inhibitors Market, Sub-Segmentation Of Pantoprazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet Formulations
• Injectable Formulations
• 6.5. Global Proton Pump Inhibitors Market, Sub-Segmentation Of Omeprazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Over-The-Counter (OTC) Omeprazole
• Prescription Omeprazole
• 6.6. Global Proton Pump Inhibitors Market, Sub-Segmentation Of Lansoprazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fast-Acting Lansoprazole
• Delayed-Release Lansoprazole
• 6.7. Global Proton Pump Inhibitors Market, Sub-Segmentation Of Esomeprazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Esomeprazole
• Intravenous Esomeprazole
• 6.8. Global Proton Pump Inhibitors Market, Sub-Segmentation Of Rabeprazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rabeprazole Tablets
• Extended-Release Rabeprazole
• 6.9. Global Proton Pump Inhibitors Market, Sub-Segmentation Of Dexlansoprazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Dexlansoprazole
• Modified-Release Dexlansoprazole
• 6.10. Global Proton Pump Inhibitors Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combination Formulations
• Lesser-Known PPIs

7. Proton Pump Inhibitors Market Regional And Country Analysis

• 7.1. Global Proton Pump Inhibitors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Proton Pump Inhibitors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Proton Pump Inhibitors Market

• 8.1. Asia-Pacific Proton Pump Inhibitors Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Proton Pump Inhibitors Market

• 9.1. China Proton Pump Inhibitors Market Overview
• 9.2. China Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Proton Pump Inhibitors Market

• 10.1. India Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Proton Pump Inhibitors Market

• 11.1. Japan Proton Pump Inhibitors Market Overview
• 11.2. Japan Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Proton Pump Inhibitors Market

• 12.1. Australia Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Proton Pump Inhibitors Market

• 13.1. Indonesia Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Proton Pump Inhibitors Market

• 14.1. South Korea Proton Pump Inhibitors Market Overview
• 14.2. South Korea Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Proton Pump Inhibitors Market

• 15.1. Western Europe Proton Pump Inhibitors Market Overview
• 15.2. Western Europe Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Proton Pump Inhibitors Market

• 16.1. UK Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Proton Pump Inhibitors Market

• 17.1. Germany Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Proton Pump Inhibitors Market

• 18.1. France Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Proton Pump Inhibitors Market

• 19.1. Italy Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Proton Pump Inhibitors Market

• 20.1. Spain Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Proton Pump Inhibitors Market

• 21.1. Eastern Europe Proton Pump Inhibitors Market Overview
• 21.2. Eastern Europe Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Proton Pump Inhibitors Market

• 22.1. Russia Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Proton Pump Inhibitors Market

• 23.1. North America Proton Pump Inhibitors Market Overview
• 23.2. North America Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Proton Pump Inhibitors Market

• 24.1. USA Proton Pump Inhibitors Market Overview
• 24.2. USA Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Proton Pump Inhibitors Market

• 25.1. Canada Proton Pump Inhibitors Market Overview
• 25.2. Canada Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Proton Pump Inhibitors Market

• 26.1. South America Proton Pump Inhibitors Market Overview
• 26.2. South America Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Proton Pump Inhibitors Market

• 27.1. Brazil Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Proton Pump Inhibitors Market

• 28.1. Middle East Proton Pump Inhibitors Market Overview
• 28.2. Middle East Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Proton Pump Inhibitors Market

• 29.1. Africa Proton Pump Inhibitors Market Overview
• 29.2. Africa Proton Pump Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Proton Pump Inhibitors Market, Segmentation By Disease Allocation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Proton Pump Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Proton Pump Inhibitors Market Competitive Landscape And Company Profiles

• 30.1. Proton Pump Inhibitors Market Competitive Landscape
• 30.2. Proton Pump Inhibitors Market Company Profiles
  • 30.2.1. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Cadila Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eisai Pharmaceuticals India Pvt. Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Wyeth LLC Overview, Products and Services, Strategy and Financial Analysis

31. Proton Pump Inhibitors Market Other Major And Innovative Companies

• 31.1. Eli Lilly and Company
• 31.2. Bayer AG
• 31.3. Takeda Pharmaceutical Company
• 31.4. Santarus Inc.
• 31.5. Janssen Pharmaceuticals
• 31.6. GlaxoSmithKline plc
• 31.7. Changzhou Siyao Pharmaceuticals
• 31.8. Yangzhou Pharmaceutical
• 31.9. Sanofi S.A.
• 31.10. Johnson & Johnson
• 31.11. Novartis International AG
• 31.12. Teva Pharmaceutical Industries Ltd.
• 31.13. Mylan N.V.
• 31.14. Sun Pharmaceutical Industries Ltd.
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Proton Pump Inhibitors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Proton Pump Inhibitors Market

34. Recent Developments In The Proton Pump Inhibitors Market

35. Proton Pump Inhibitors Market High Potential Countries, Segments and Strategies

• 35.1 Proton Pump Inhibitors Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Proton Pump Inhibitors Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Proton Pump Inhibitors Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer